EUVIMEDEUVIMED entdecken
Open Access

CES1 is associated with cisplatin resistance and poor prognosis of head and neck squamous cell carcinoma

Chuan Jiang, Chunlei Liu, X I Yao, Jingya Su, Wei Lu, Zhengbo Wei, Ying Xie

Oncology Research · 2024 · 32 (12) · 1935-1948

DOI: 10.32604/or.2024.052244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Chuan Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry ofEducation, Nanning, 53000…. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug Resistance, NeoplasmSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsCarboxylic Ester HydrolasesHumansPrognosisCell Line, TumorMaleFemaleGene Expression Regulation, NeoplasticAntineoplastic AgentsMiddle AgedBiomarkers, Tumor

Stichwörter der Autor:innen

Carboxylesterase 1 (CES1)ChemoresistanceCisplatinHead and neck squamous cell carcinoma (HNSCC)PrognosisSmoking

Substanzen

CisplatinCES1 protein, humanCarboxylic Ester HydrolasesAntineoplastic AgentsBiomarkers, Tumor

Autor:innen und Institutionen

  • Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry ofEducation, Nanning, 530000, China.
  • Life Sciences Institute, Guangxi Medical University, Nanning, 530000, China.
  • Department of Head and Neck Tumor Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530000, China.

Zitieren

APA

Jiang, C., Liu, C., Yao, X. I., Su, J., Lu, W., Wei, Z., & Xie, Y. (2024). CES1 is associated with cisplatin resistance and poor prognosis of head and neck squamous cell carcinoma. Oncology Research, 32(12), 1935-1948. https://doi.org/10.32604/or.2024.052244

Vancouver

Jiang C, Liu C, Yao XI, Su J, Lu W, Wei Z, et al. CES1 is associated with cisplatin resistance and poor prognosis of head and neck squamous cell carcinoma. Oncology Research. 2024;32(12):1935-1948. doi:10.32604/or.2024.052244

BibTeX
@article{Jiang2024,
  author = {Jiang, Chuan and Liu, Chunlei and Yao, X I and Su, Jingya and Lu, Wei and Wei, Zhengbo and Xie, Ying},
  title = {CES1 is associated with cisplatin resistance and poor prognosis of head and neck squamous cell carcinoma},
  journal = {Oncology Research},
  year = {2024},
  volume = {32},
  number = {12},
  pages = {1935--1948},
  doi = {10.32604/or.2024.052244}
}
Kostenlos starten →